JOHN C. BOLGER - 01 Mar 2022 Form 4 Insider Report for Fulgent Genetics, Inc. (FLGT)

Role: Director
Signature: /s/ Paul Kim, as Attorney-in-fact
Issuer symbol: FLGT
Transactions as of: 01 Mar 2022
Net transactions value: -$99,085
Form type: 4
Filing time: 03 Mar 2022, 16:01:08 UTC
Previous filing: 01 Sep 2021
Next filing: 20 May 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	FLGT	Common Stock	Options Exercise	$2,453	+625	+31%	$3.92^*	2,625	01 Mar 2022	Direct
transaction	FLGT	Common Stock	Sale	$38,388	-625	-24%	$61.42	2,000	01 Mar 2022	Direct	F1
transaction	FLGT	Common Stock	Options Exercise	$3,631	+625	+31%	$5.81^*	2,625	01 Mar 2022	Direct
transaction	FLGT	Common Stock	Sale	$38,376	-625	-24%	$61.40	2,000	01 Mar 2022	Direct
transaction	FLGT	Common Stock	Options Exercise	$9,888	+625	+31%	$15.82	2,625	01 Mar 2022	Direct
transaction	FLGT	Common Stock	Sale	$38,293	-625	-24%	$61.27	2,000	01 Mar 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	FLGT	Stock Option (Right to Buy)	Options Exercise	$0	-625	-67%	$0.000000	313	01 Mar 2022	Common Stock	625	$3.92	Direct	F2
transaction	FLGT	Stock Option (Right to Buy)	Options Exercise	$0	-625	-29%	$0.000000	1,563	01 Mar 2022	Common Stock	625	$5.81	Direct	F3
transaction	FLGT	Stock Option (Right to Buy)	Options Exercise	$0	-625	-18%	$0.000000	2,813	01 Mar 2022	Common Stock	625	$15.82	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares were sold in multiple transactions at prices ranging from $61.0767 to $61.4400, inclusive. The reported price reflects the weighted-average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.
F2	The shares subject to the option vest over a period of four years, with 1/4th of such units vesting 12 months after May 18 2018, and 1/16th of such shares vesting at the end of every three-month period over the 36 months thereafter, subject to the reporting person's continued service for the Issuer on each vesting date.
F3	The shares subject to the option vest over a period of four years, with 1/4th of such units vesting 12 months after May 30, 2019, and 1/16th of such shares vesting at the end of every three-month period over the 36 months thereafter, subject to the reporting person's continued service for the Issuer on each vesting date.
F4	The shares subject to the option vest over a period of four years, with 1/4th of such units vesting 12 months after May 27, 2020, and 1/16th of such shares vesting at the end of every three-month period over the 36 months thereafter, subject to the reporting person's continued service for the Issuer on each vesting date.